Risk factors and preventive interventions for post Covid-19 condition: systematic review

Emerg Microbes Infect. 2022 Dec;11(1):2762-2780. doi: 10.1080/22221751.2022.2140612.

Abstract

This systematic review examined pre-existing and clinical risk factors for post Covid-19 condition (≥12 weeks after onset), and interventions during acute and post-acute phases of illness that could potentially prevent post Covid-19 condition. The review focuses on studies collecting data during the early phases of the pandemic and prior to the emergence of variants of concern and widespread vaccination. We searched bibliographic databases and grey literature. Two investigators independently reviewed abstracts and full-text articles, and data extraction and risk of bias assessments were verified. Meta-analysis was performed when suitable and we assessed the certainty of evidence using GRADE. We included 31 studies. We found small-to-moderate associations (e.g. adjusted odds ratios 1.5 to <2.0) between female sex and higher non-recovery, fatigue, and dyspnea (moderate certainty). Severe or critical acute-phase Covid-19 severity (versus not) has probably (moderate certainty) a large association (adjusted ratio ≥2.0) with increased cognitive impairment, a small-to-moderate association with more non-recovery, and a little-to-no association with dyspnea. There may be (low certainty) large associations between hospitalization and increased non-recovery, increased dyspnea, and reduced return to work. Other outcomes had low certainty of small-to-moderate or little-to-no association or very low certainty. Several potential preventive interventions were examined, but effects are very uncertain. Guidelines in relation to surveillance, screening, and other services such as access to sickness and disability benefits, might need to focus on females and those with previously severe Covid-19 illness. Continuous assessment of emerging evidence, especially on whether different variants and vaccination impact outcomes, will be important. PROSPERO registration: CRD42021270354.

Keywords: Post COVID-19 condition; interventions; prevention; risk factors; systematic review.

Publication types

  • Systematic Review
  • Meta-Analysis

MeSH terms

  • COVID-19* / prevention & control
  • Dyspnea
  • Female
  • Humans
  • Pandemics / prevention & control
  • Risk Factors
  • Vaccination

Grants and funding

The Public Health Agency of Canada (PHAC) funded this work. The funder had no role in the conduct of this research, nor did it decide whether or not to publish the results. Dr. Hartling is supported by a Canada Research Chair in Knowledge Synthesis and Translation, and is a Distinguished Researcher with the Stollery Science Lab supported by the Stollery Children’s Hospital Foundation.